(NASDAQ: EPIX) Essa Pharma's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 5.19%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 14.9%.
Essa Pharma's earnings in 2025 is -$25,265,209.On average, 1 Wall Street analyst forecast EPIX's earnings for 2025 to be -$14,665,602, with the lowest EPIX earnings forecast at -$14,665,602, and the highest EPIX earnings forecast at -$14,665,602. On average, 1 Wall Street analyst forecast EPIX's earnings for 2026 to be $7,569,343, with the lowest EPIX earnings forecast at $7,569,343, and the highest EPIX earnings forecast at $7,569,343.
In 2027, EPIX is forecast to generate $143,344,434 in earnings, with the lowest earnings forecast at $143,344,434 and the highest earnings forecast at $143,344,434.